SS

Stephen P. Squinto

AP Alexion Pharmaceuticals: 12 patents #6 of 226Top 3%
RP Regeneron Pharmaceuticals: 8 patents #150 of 810Top 20%
YU Yale University: 4 patents #188 of 1,662Top 15%
OF Oklahoma Medical Research Foundation: 3 patents #40 of 184Top 25%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
Overall (All Time): #174,093 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
9771418 Methods for treating complement-associated disorders Russell P. Rother, Camille Bedrosian, Leonard Bell 2017-09-26
9447176 Methods and compositions for treating complement-associated disorders Russell P. Rother, Camille Bedrosian, Leonard Bell 2016-09-20
7041503 Modified myelin basic protein molecules Steven H. Nye, Michael J. Lenardo, Henry F. McFarland, Louis A. Matis, Eileen Elliott Mueller +3 more 2006-05-09
6916654 Universal donor cells Peter J. Sims, Alfred Bothwell, Eileen A. Elliot, Richard Flavell, Joseph Madri +2 more 2005-07-12
6905657 Methods and devices for storing and dispensing liquids Allyn Hubbard, Samesh Kale, Scott Rollins, Jeremy P. Springhorn, Prasad R. Akkapeddi 2005-06-14
6355245 C5-specific antibodies for the treatment of inflammatory diseases Mark Evans, Louis A. Matis, Eileen Elliott Mueller, Steven H. Nye, Scott Rollins +4 more 2002-03-12
6338820 Apparatus for performing assays at reaction sites Allyn Hubbard, Samesh Kale, Scott Rollins, Jeremy P. Springhorn 2002-01-15
6316206 Method for screening comprising cells expressing the CNTF receptor Samuel Davis, Mark E. Furth, George D. Yancopoulos 2001-11-13
6100443 Universal donor cells Peter J. Sims, Alfred Bothwell, Eileen A. Elliot, Richard Flavell, Joseph Madri +2 more 2000-08-08
5892003 Ciliary neurotrophic factor receptor antibodies Samuel Davis, Mark E. Furth, George D. Yancopoulos 1999-04-06
5871997 Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes Russell P. Rother, Scott Rollins, William Fodor, Jeremy P. Springhorn 1999-02-16
5853722 Use of C5-specific antibodies for reducing immune and hemostatic dysfunctions during extracorporeal circulation Scott Rollins, Brian Smith 1998-12-29
5849897 Nucleic acid molecule encoding ciliary neurotrophic factor receptor Samuel Davis, Mark E. Furth, George D. Yancopoulos 1998-12-15
5847082 Terminal complement inhibitor fusion proteins Russell P. Rother, Scott Rollins 1998-12-08
5705732 Universal donor cells Peter J. Sims, Alfred Bothwell, Eileen A. Elliot, Richard Flavell, Joseph Madri +2 more 1998-01-06
5648334 Methods of treatment using ciliary neurotrophic factor Samuel Davis, Mark E. Furth, George D. Yancopoulos 1997-07-15
5643770 Retroviral vector particles expressing complement inhibitor activity James M. Mason 1997-07-01
5627264 Chimeric complement inhibitor proteins William Fodor, Scott Rollins 1997-05-06
5624837 Nucleic acid encoding chimeric complement inhibitor proteins William Fodor, Scott Rollins 1997-04-29
5622862 Assay systems for trkB neurotrophin activity David Glass, Thomas H. Aldrich, Peter Distefano, Trevor Stitt, Mark E. Furth +1 more 1997-04-22
5562904 Retroviral transduction of cells using soluble complement inhibitors Russell P. Rother, Scott Rollins, James M. Mason 1996-10-08
5512661 Multitrophic and multifunctional chimeric neurotrophic factors Eric M. Shooter, Ulrich Suter, Nancy Ip, Mark E. Furth, Ronald M. Lindsay 1996-04-30
5426177 Ciliary neurotrophic factor receptor Samuel Davis, Mark E. Furth, George D. Yancopoulos 1995-06-20
5169764 Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras Eric M. Shooter, Ulrich Suter, Nancy Ip, Mark E. Furth, Ronald M. Lindsay +1 more 1992-12-08